Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Find Full text
Thumbnail
Fulltext:
216639.pdf
Embargo:
until further notice
Size:
668.7Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2020
Author(s)
Ariens, Lieneke F.M.
Schaft, Jorien van der
Bakker, Daphne S.
Balak, Deepak
Romeijn, Margreet L.E.
Kouwenhoven, T.A.
Kamsteeg, M.
Schuttelaar, Marie L.A.
Bruin-Weller, Marjolein S. de
Source
Allergy, 75, 1, (2020), pp. 116-126
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/216639   https://hdl.handle.net/2066/216639
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.